Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion type Assertion NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_head.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion description "[Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion evidence source_evidence_literature NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion SIO_000772 24877854 NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion wasDerivedFrom befree-2016 NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion wasGeneratedBy ECO_0000203 NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.